BioTek Instruments, Inc., welcomes Dr. Charles Amirmansour to the company as Canadian Applications & Business Development Manager. Dr. Amirmansour is responsible for supporting BioTek's technical and new business activities with Fisher Scientific Canada.

"Dr. Amirmansour has a unique set of skills, creating cutting-edge business development programs, with an extensive background in life science and drug discovery applications," notes Gary Barush, BioTek's Director of Marketing & Sales. "Additionally, his strong academic background will resonate with our research-based microplate technologies."

Prior to joining BioTek, Dr. Amirmansour held various positions at PerkinElmer, Inc., most recently as Product Line Leader and Sr. Technology Specialist. Following the receipt of his doctorate in clinical pharmacology, Dr. Amirmansour worked as a post-doctoral research fellow at The William Harvey Research Institute, National Heart & Lung Institute and Harefield Heart Science Centre under the supervision of Nobel Laureates, Professors Sir John Vane and Sir Magdy Yacoub.

We congratulate Dr. Amirmansour as he assumes his new responsibilities.

BioTek Instruments, Inc., headquartered in Winooski, VT, USA, is a worldwide leader in the design, manufacture, and sale of microplate instrumentation and software. BioTek instrumentation is used to aid in the advancement of life science research, facilitate the drug discovery process and to enable cost-effective quantification of disease relevant molecules in the clinic.

For further information please visit www.biotek.com